non-insulin-dependent diabetes type 2 diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Diagnosis of type 2 diabetes made by a medical doctor at least 6 months prior to study enrolment • Adult • Willing and able to follow dietary intervention • Willing to participate in both intervention and control group • Living at a reasonable distance from the research center at Wageningen University & Research (WUR) (i.e. maximum of ± 1 hour away)
Exclusion criteria
Exclusion criteria: • Currently treated with insulin therapy • Recently (
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameter is the difference in change in cardiometabolic risk profile (HbA1c, LDL-cholesterol, blood pressure and body weight) from baseline until six months between the intervention and the control group. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary parameters include a diet quality score for the level of adherence to the Dutch dietary guidelines, blood lipid profile, markers of glucose metabolism, kidney, and liver function, muscle quality and physical performance, patient-oriented outcomes such as medical consumption, productivity, sleep quality, food literacy, quality of life and self-efficacy. These parameters are assessed in blood and 24-hour urine, and by means of measuring body weight, blood pressure, making ultrasound of the leg, fitness tests, a dietary recall, and self-administered questionnaires. To assess whether effects remain after the active intervention period has ended, differences in change between intervention and control group will also be investigated six months after the intervention, i.e. 12 months after the start of the study. | — |
Countries
Netherlands